Kronos Bio Announces CEO Transition and Reduction in Force – BioSpace

SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 27, 2024 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company developing small molecule …

Continue

Do you trust this headline?

Based on recent headline ratings, 82% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending positivenegative.

82%

Media Trust Score82%

Read All

In

News